Invicta Diagnostic Limited (NSE:INVICTA)

India · Delayed Price · Currency is INR

69.50

-0.15 (-0.22%)

At close: Aug 20, 2026

-30.50% (1Y)

Market Cap	873.75M
Revenue (ttm)	330.42M +382.9%
Net Income	49.06M
EPS	4.90
Shares Out	12.57M
PE Ratio	14.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,400
Open	69.50
Previous Close	69.65
Day's Range	69.50 - 69.50
52-Week Range	58.10 - 105.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo... [Read more]

Industry Medical Laboratories

Founded 2016

Employees 113

Stock Exchange National Stock Exchange of India

Ticker Symbol INVICTA

Full Company Profile

Financial Performance

In fiscal year 2026, Invicta Diagnostic's revenue was 330.42 million, an increase of 9.48% compared to the previous year's 301.81 million. Earnings were 49.06 million, an increase of 0.30%.

Financial Statements